Envoy Medical (COCH) Net Equity Issued and Repurchased (2024 - 2026)

Envoy Medical (COCH) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $30.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $30.0 million; the trailing twelve-month figure through Mar 2026 stood at $30.2 million (changed N/A YoY), and the FY2025 full-year result was $414000.0, changed N/A from the prior year.
• Net Equity Issued and Repurchased climbed to $30.0 million in Q1 2026, from $210000.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $30.0 million in Q1 2026 to a low of $210000.0 in Q3 2025.
• A 3-year average of $10.6 million and a median of $1.7 million in 2024 frame the typical range for Net Equity Issued and Repurchased.